Veracyte (VCYT) Net Cash Flow (2016 - 2025)
Veracyte (VCYT) has disclosed Net Cash Flow for 14 consecutive years, with $47.0 million as the latest value for Q4 2025.
- Quarterly Net Cash Flow rose 237.73% to $47.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122.9 million through Dec 2025, up 417.92% year-over-year, with the annual reading at $122.9 million for FY2025, 417.92% up from the prior year.
- Net Cash Flow hit $47.0 million in Q4 2025 for Veracyte, down from $96.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $96.0 million in Q3 2025 to a low of -$163.6 million in Q3 2021.
- Historically, Net Cash Flow has averaged $795350.0 across 5 years, with a median of $10.2 million in 2021.
- Biggest five-year swings in Net Cash Flow: surged 352.74% in 2023 and later crashed 661.51% in 2025.
- Year by year, Net Cash Flow stood at $9.0 million in 2021, then crashed by 284.33% to -$16.6 million in 2022, then soared by 182.55% to $13.7 million in 2023, then plummeted by 349.1% to -$34.1 million in 2024, then surged by 237.73% to $47.0 million in 2025.
- Business Quant data shows Net Cash Flow for VCYT at $47.0 million in Q4 2025, $96.0 million in Q3 2025, and $32.8 million in Q2 2025.